BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 31101924)

  • 1. [Infantile haemangioma: an update].
    Reimer A; Ott H
    Hautarzt; 2019 Jun; 70(6):447-458. PubMed ID: 31101924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Infantile haemangioma: clinical and demographic characteristics, experiences in the treatment].
    Csoma ZR; Dalmády S; Ábrahám R; Rózsa T; Rácz K; Kemény L
    Orv Hetil; 2017 Oct; 158(39):1535-1544. PubMed ID: 28942665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Propranolol therapy for periocular and orbital infantile haemangiomas].
    Sterker I; Tegetmeyer H; Sorge I; Weißer M; Böhm R
    Klin Monbl Augenheilkd; 2014 Oct; 231(10):971-9. PubMed ID: 25333232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A further experience of propranolol for severe infantile hemangiomas of the face: an observational study.
    Greco A; D'Erme AM; Zamma Gallarati B; Caputo R; de Martino M
    Dermatol Ther; 2014; 27(4):198-202. PubMed ID: 24548454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infantile haemangiomas: a challenge in paediatric dermatology.
    Schwartz RA; Sidor MI; Musumeci ML; Lin RL; Micali G
    J Eur Acad Dermatol Venereol; 2010 Jun; 24(6):631-8. PubMed ID: 20565561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Propranolol in infantile hemangiomas].
    Léauté-Labrèze C
    Arch Pediatr; 2015 Apr; 22(4):452-5. PubMed ID: 25753275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective analysis of systemic propranolol for the treatment of complicated infantile haemangiomas.
    Schneider M; Cremer HJ; Ruef P
    Acta Paediatr; 2014 Sep; 103(9):977-83. PubMed ID: 24837972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propranolol: useful therapeutic agent for the treatment of ulcerated infantile hemangiomas.
    Kim LHC; Hogeling M; Wargon O; Jiwane A; Adams S
    J Pediatr Surg; 2011 Apr; 46(4):759-763. PubMed ID: 21496551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propranolol for infantile haemangiomas: single centre experience of 250 cases and proposed therapeutic protocol.
    Solman L; Murabit A; Gnarra M; Harper JI; Syed SB; Glover M
    Arch Dis Child; 2014 Dec; 99(12):1132-6. PubMed ID: 25123404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and management of infantile hemangiomas.
    Püttgen KB
    Pediatr Clin North Am; 2014 Apr; 61(2):383-402. PubMed ID: 24636652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propranolol-resistant infantile haemangiomas.
    Caussé S; Aubert H; Saint-Jean M; Puzenat E; Bursztejn AC; Eschard C; Mahé E; Maruani A; Mazereeuw-Hautier J; Dreyfus I; Miquel J; Chiaverini C; Boccara O; Hadj-Rabia S; Stalder JF; Barbarot S;
    Br J Dermatol; 2013 Jul; 169(1):125-9. PubMed ID: 23659587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features of cutaneous infantile hemangioma combined with asymptomatic infantile hepatic hemangioma and efficacy of propranolol treatment.
    Li L; Yu L; Xu Z; Wei L; Zhang B; Han X; Sun Y; Ma L
    J Cosmet Dermatol; 2023 Dec; 22(12):3369-3374. PubMed ID: 37313653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symplastic hemangioma developing over an infantile hemangioma during propranolol treatment.
    Downey C; Pino G; Zambrano MJ; Kramer D; Cervilla K; González S
    Pediatr Dermatol; 2019 Nov; 36(6):961-962. PubMed ID: 31468563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Infantile hemangioma and propranolol: a therapeutic "revolution". Literature review].
    Yilmaz L; Dangoisse C; Semaille P
    Rev Med Brux; 2013; 34(6):479-84. PubMed ID: 24505868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propranolol in the treatment of problematic infantile hemangioma: review of 35 consecutive patients from a vascular anomalies clinic.
    Bertrand J; Sammour R; McCuaig C; Dubois J; Hatami A; Ondrejchak S; Boutin C; Bortoluzzi P; Laberge LC; Powell J
    J Cutan Med Surg; 2012; 16(5):317-23. PubMed ID: 22971306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of propranolol for the treatment of infantile hemangioma: a presentation of ninety-nine cases.
    Sagi L; Zvulunov A; Lapidoth M; Ben Amitai D
    Dermatology; 2014; 228(2):136-44. PubMed ID: 24556822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of infantile hemangiomas with beta-blockers: a review.
    Shah S; Frieden IJ
    Skin Therapy Lett; 2013; 18(6):5-7. PubMed ID: 24305730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propranolol for treatment of ulcerated infantile hemangiomas.
    Saint-Jean M; Léauté-Labrèze C; Mazereeuw-Hautier J; Bodak N; Hamel-Teillac D; Kupfer-Bessaguet I; Lacour JP; Naouri M; Vabres P; Hadj-Rabia S; Nguyen JM; Stalder JF; Barbarot S;
    J Am Acad Dermatol; 2011 May; 64(5):827-32. PubMed ID: 21353332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemangioma: clinical course, complications and management.
    Luu M; Frieden IJ
    Br J Dermatol; 2013 Jul; 169(1):20-30. PubMed ID: 23701395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propranolol as first-line treatment for rapidly proliferating infantile haemangiomas.
    Holmes WJ; Mishra A; Gorst C; Liew SH
    J Plast Reconstr Aesthet Surg; 2011 Apr; 64(4):445-51. PubMed ID: 20797926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.